-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Stroke is the main cause of death and long-term disability, and it has become an important global public health problem
.
Among all complications of stroke survivors, post-stroke depression (PSD) is the most common mental problem
Stroke quality of life
However, the effect of serum growth differentiation factor 15 (GDF-15) on PSD is still unknown
.
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, the purpose of this study was to investigate the correlation between serum levels of GDF 15-PSD patients with ischemic stroke
Blood vessel
The study is based on a random sample from CATIS (Chinese Acute Ischemic Stroke Antihypertensive Trial) and analyzed the GDF-15 levels of 572 patients from 7 participating hospitals
.
The result of the study was depressive symptoms (Hamilton Depression Scale score ≥ 8) that appeared 3 months after ischemic stroke
hypertension
A total of 231 (40.
4%) stroke patients in the study experienced PSD within 3 months
.
Compared with the lowest tertile, the multivariate adjusted odds ratio of PSD associated with the highest tertile of serum GDF-15 levels was 2.
It can be seen that the increase of serum GDF-15 level in the acute phase of ischemic stroke is independently related to PSD, indicating that GDF-15 level may be a valuable prognostic biomarker of PSD
.
.
Original source:
Original source:Yuhan Zang,et al.